Piañar, Kathleen Marlet E.
HRN: 00013-27-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2022
CEFTRIAXONE 1G (VIAL)
10/16/2022
10/22/2022
IVT
2g
Q24hrs
UtI; R/o Agn
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes